Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shui On Group is a prominent Hong Kong-based conglomerate that has strategically expanded its core property and construction business into the life sciences and healthcare sectors. Through its dedicated platform, Shui On Life Science, the group develops large-scale innovation hubs and life science parks, such as the Knowledge and Innovation Community (KIC) in Shanghai and Wuhan Optics Valley Innovation Tiandi, which provide essential infrastructure for biotech and pharmaceutical companies. Additionally, the group acts as a strategic investor in the healthcare space, with notable interests in New Frontier Health (United Family Healthcare) and the Sino-American incubator InnoSpring. Shui On Group's activities are focused on fostering a comprehensive ecosystem that supports research, development, and cross-border technology transfer within the biopharmaceutical industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shui On Group.